tirzepatide stronger than semaglutide caused roughly half as many patients to stop treatment because of gastrointestinal side effects as semaglutide. In the first major head-to-head obesity trial, GI side effects caused treatment discontinuation in: Tirzepatide is retatrutide better than tirzepatide

These findings indicate that adding reduced glutathione to entecavir therapy could be a highly effective approach for managing chronic hepatitis B, particularly for improving liver function and accelerating viral clearance

Clinicians should refer to official prescribing information, regulatory updates, and conduct individualized patient assessments when making therapeutic decisions

Based on the characteristics of the patients intestinal microbiome, personalized microbiome intervention plans should be formulated

Remote Pharmacy, as a telehealth platform, facilitates the connection between patients and U.S.-licensed physicians, ensuring safe and convenient access to prescription-based weight management options

If a patient feels unusually sad, anxious, or irritable, they should discuss this with their healthcare provider

Retrieved from Hausner, H., Derving Karsbl, J., Holst, A